Additionally, Skolekova and co-authors demonstrated that the pre-exposure of MSCs to cisplatin altered the phosphorylation of several tyrosine kinases, including STAT3, c-Jun, WNK-1, and p53, promoting the production of IL-6 and IL-8 and MSC survival, leading to tumor cell chemoresistance [259]. The gene discussed is IL6; the disease is neoplasm.